Stock Insights: Express Scripts Holding Company (NASDAQ:ESRX)

[GlobeNewswire] Express Scripts Holding Company (NASDAQ:ESRX) the largest pharmacy benefit management company in North America, announced today its intention to release its third quarter earnings on Tuesday, October 28, 2014 after the market closes and will hold its quarterly conference call to discuss third quarter results on Wednesday, October 29, 2014, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time).Stock PerformanceTaking a look at the company’s recent performance, Express Scripts Holding Company (ESRX) reported second quarter earnings for fiscal year 2014 on July 29th 2014. The company reported actual earnings per share of $1.23 against the consensus Street estimate of $1.22. This represents year over year growth of 8.94%. ESRX posted revenue of $25.11 billion against estimates of $24.42billion.Express Scripts Holding Company (ESRX) is currently valued at $52.77 billion and closed the last trading session at $70.74. The stock has a 50-day moving average of $73.69 and a 200-day moving average of $71.30.

Is this a Buying Opportunity?There are currently eighteen analysts that we track that cover the stock. Of those eighteen, thirteen have Buy rating and five have a hold rating. On a consensus basis this yields a score of 2.72 and a Buy. The combined price objective of these covering analysts is $80.06, which represents a 12.12% upside difference to the last closing price.The most recent analyst activity consisted of Zacks reiterating their neutral stance of the company. On the date of the report, the stock closed at $74.35.Another research firm weighing in recently was Goldman Sachs who downgrade their buy neutral Coverage on the stock. On July 24^th 2014 Goldman Sachs upgrade their price target on the stock $75.00, to $75.05 a 4.82% upside to the current price. On the day of the report, ESRX shares closed at $4.85.Company Profile Express Scripts Holding Company (ESRX) provides a range of pharmacy benefit management (PBM) services primarily in the United States and Canada. The company offers healthcare management and administration services on behalf of its clients. It operates in two segments, PBM and Other Business Operations. The company’s PBM services comprise retail network pharmacy administration; home delivery pharmacy; benefit design consultation; drug utilization review; drug formulary management; clinical solutions to improve health outcomes; an array of Medicare Part D, Medicaid, and health insurance marketplace; specialty pharmacy services, such as the distribution of fertility pharmaceuticals that require special handling or packaging; bio- pharmaceutical services, including reimbursement and logistics solutions; group purchasing organization administration; and consumer health and drug information services.